Turunc has advised Pollet Medical Group on obtaining the approval of the Turkish Competition Board for the majority acquisition of Farmasol.
Turunc Advises Pollet Medical Group on Approval for Acquisition of Farmasol
E+H and Baker McKenzie Advise on Ligand Pharmaceuticals Incorporated's Acquisition of Apeiron Biologics
E+H, working with McDermott Will & Emery, has advised Ligand Pharmaceuticals Incorporated on its acquisition of Apeiron Biologics. Baker McKenzie advised Apeiron's shareholders. Dorda reportedly advised Apeiron.
DZP Advises Rubicon Partners on USD 2.5 Million Investment in StaffHealth
DZP, working with Orrick, has advised Rubicon Partners on its USD 2.5 million investment in StaffHealth.
Kinstellar Advises Edwards Lifesciences on Data Protection Matters
Kinstellar has advised Edwards Lifesciences on data protection legal matters via a secondment arrangement.
Ellex Advises Specialist VC on Leading a EUR 1.75 Million Investment Round for Nanordica Medical
Ellex has advised Specialist VC as the lead investor on the EUR 1.75 million seed round for Estonian medtech company Nanordica Medical.
EY Law advises Rohto on Acquisition of Sigmapharm/MoNo Chem-Pharm Group
EY Law has advised Rohto on its acquisition of the Austrian Sigmapharm/MoNo chem-pharm group.
Dentons Advises RIB on Financing Farmak’s Entry in Spain
Dentons has advised Regionala Investiciju Banka on its financing of Farmak. Cuatrecasas reportedly advised Farmak.
More Articles ...
Our Latest Issue
The Digital Euro: A Look at CBDCs in Europe
The Debrief: August, 2024
